Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension

Joanna Sladowska-Kozłowska1, Mieczysław Litwin, Anna Niemirska

  • 1Department of Nephrology and Arterial Hypertension, The Children's Memorial Health Institute, Warsaw, Poland.

Insights

In children with primary hypertension, left ventricular (LV) geometry changes are linked to obesity and insulin resistance. Reducing abdominal obesity and improving insulin sensitivity are key to normalizing LV geometry.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Metabolic Syndrome

Background:

  • Left ventricular (LV) geometry is crucial in adult hypertension.
  • Understanding LV geometry changes in pediatric primary hypertension (PH) is vital.
  • Metabolic and anthropometrical factors may influence LV geometry in hypertensive children.

Purpose of the Study:

  • To analyze changes in LV geometry after one year of antihypertensive treatment in children with PH.
  • To identify determinants of LV geometry changes, focusing on metabolic abnormalities and anthropometrical parameters.
  • To assess the impact of treatment on LV geometry in pediatric PH.

Main Methods:

  • Assessed LV geometry and biochemical parameters in 86 children with newly diagnosed PH before and after 12 months of treatment.
  • Classified baseline LV geometry into normal geometry (NG), concentric remodeling (CR), concentric hypertrophy (CH), and eccentric hypertrophy (EH).
  • Analyzed the relationship between LV geometry, visceral obesity, and metabolic parameters like the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio.

Main Results:

  • At baseline, 48.9% had NG, 4.6% CR, 9.3% CH, and 37.2% EH. Patients with CH and EH showed greater visceral obesity.
  • After 12 months of antihypertensive treatment, the prevalence of EH decreased significantly (37.2% to 18.6%), while CH prevalence remained unchanged.
  • A decrease in the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio was the main predictor of decreased relative wall thickness (RWT) and normalization of LV geometry.

Conclusions:

  • LV geometry in adolescents with PH is associated with central obesity and insulin resistance.
  • Decreased abdominal obesity and improved insulin resistance are critical for normalizing LV geometry.
  • Concentric hypertrophy (CH) demonstrates a lower potential for normalization compared to other LV geometry patterns.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...